It is anticipated to have a favorable response to treatment in patients with lower disease activity, however, it would be illuminative if the authors could perform testing for both IgE autoantibodies and IgG autoantibodies and determine which type of autoimmunity these patients have. This evidence concerns the gene IGHE and Autoimmunity.